| Gene Symbol G ~ P |
|
| Cat# | GENE Symbol | Gene Name | Alternative Name | NCBI Accession | | LVP039 | GAK | cyclin G associated kinase | FLJ16629, FLJ40395, MGC99654 | NM_005255 | | LVP040 | GALK2 | galactokinase 2 | GK2, MGC1745 | NM_002044.2 | | LVP074 | GBA | glucosidase, beta, acid | GBA1, GCB, GLUC | NM_000157.3 | | LVP045 | GCK | glucokinase (hexokinase 4) | FGQTL3, GK, GLK, HHF3, HK4, HKIV, HXKP, LGLK, MODY2 | NM_000162.3 | | LVP273 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | KIAA0154 | NM_014001.2 | | LVP015 | GLUL | glutamate-ammonia ligase (glutamine synthetase) | GS; GLNS; PIG43; PIG59 | NM_002065.4 | | LVP076 | GORASP2 | golgi reassembly stacking protein 2, 55kDa | DKFZp434D156, FLJ13139, GOLPH6, GRASP55, GRS2, p59 | NM_015530.3 | | LVP112 | GPSM3 | G-protein signaling modulator 3 (AGS3-like, C. elegans) | DAAP-218M18.6, AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1 | NM_022107.1 | | LVP046 | GRK6 | G protein-coupled receptor kinase 6 | FLJ32135, GPRK6 | NM_002082 | | LVP167 | GSK3B | glycogen synthase kinase 3 beta | | NM_002093.3 | | LVP303 | HLAG | major histocompatibility complex, class I, G | MHC-G; HLA-G | NM_002127.5 | | LVP302 | IDO1 | indoleamine 2,3-dioxygenase 1 | IDO; INDO; IDO1 | NM_002164.4 | | LVP277 | IFNG | interferon, gamma | IFG, IFI | NM_000619.2 | | LVP169 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB | NM_001556 | | LVP170 | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO | NM_003639.3 | | LVP073 | IL17BR | interleukin 17 receptor B | CRL4, EVI27, IL17BR, IL17RH1, MGC5245 | NM_018725 | | LVP293 | IL2 | interleukin 2 | IL-2; lymphokine; TCGF | NM_000586.3 | | LVP295 | IL20 | interleukin 20 | IL-20; IL10D; MGC96907; ZCYTO10 | NM_018724.3 | | LVP292 | IL3 | interleukin 3 (colony-stimulating factor, multiple) | IL-3; MCGF; MGC79398; MGC79399; MULTI-CSF | NM_000588.3 | | LVP209 | IRAK3 | interleukin-1 receptor-associated kinase 3 | ASRT5, FLJ13601, IRAKM | NM_007199 | | LVP172 | JUN | jun oncogene | AP-1, AP1, c-Jun | NM_002228.3 | | LVP290 | KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | CIR; GIRK4; KATP1; KIR3.4 | NM_000890 | | LVP294 | KITLG | KIT ligand | FPH2; Kitl; KL-1; MGF; SCF; SF; SHEP7 | NM_000899.3 | | LVP101 | LBR | lamin B receptor | DHCR14B, FLJ43126, LMN2R, MGC9041, PHA | NM_002296.2 | | LVP033 | LIMK2 | LIM domain kinase 2 | LIMK-2 | NM_005569 | | LVP174 | LMNA | lamin A/C | RP11-54H19.1, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1 | NM_005572.3 | | LVP092 | MAK | male germ cell-associated kinase | RP3-417M14.2, dJ417M14.2 | NM_005906 | | LVP176 | MAP2K2 | mitogen-activated protein kinase kinase 2 | FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2 | NM_030662.3 | | LVP177 | MAP2K3 | mitogen-activated protein kinase kinase 3 | MAPKK3, MEK3, MKK3, PRKMK3 | NM_145109.2 | | LVP178 | MAP2K4 | mitogen-activated protein kinase kinase 4 | JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SEK1, SERK1 | NM_003010 | | LVP228 | MAP2K5 | mitogen-activated protein kinase kinase 5 | HsT17454, MAPKK5, MEK5, PRKMK5 | NM_145160.1 | | LVP180 | MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | DLK, MEKK12, MUK, ZPK, ZPKP1 | NM_006301.2 | | LVP181 | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | FTDCR1B, HS, HSNIK, NIK | NM_003954 | | LVP182 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | RP3-325F22.4, ASK1, MAPKKK5, MEKK5 | NM_005923 | | LVP183 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | MEKK7, TAK1, TGF1a | NM_003188 | | LVP184 | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | RP11-449I17.8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT | NM_005204.2 | | LVP185 | MAPK1 | mitogen-activated protein kinase 1 | ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | NM_002745 | | LVP186 | MAPK12 | mitogen-activated protein kinase 12 | ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3 | NM_002969 | | LVP187 | MAPK13 | mitogen-activated protein kinase 13 | PRKM13, SAPK4, p38delta | NM_002754.3 | | LVP188 | MAPK3 | mitogen-activated protein kinase 3 | ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3 | NM_002746 | | LVP189 | MAPK6 | mitogen-activated protein kinase 6 | DKFZp686F03189, ERK3, HsT17250, PRKM6, p97MAPK | NM_002748 | | LVP190 | MAPK7 | mitogen-activated protein kinase 7 | BMK1, ERK4, ERK5, PRKM7 | NM_002749 | | LVP191 | MAPK8 | mitogen-activated protein kinase 8 | JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1 | NM_002750 | | LVP192 | MAPK9 | mitogen-activated protein kinase 9 | JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK | NM_002752 | | LVP075 | MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 3PK, MAPKAP3 | NM_004635 | | LVP195 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 | PRAK | NM_003668.2 | | LVP032 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | EMK-1, EMK1, MGC99619, PAR-1, Par1b | NM_004954 | | LVP029 | MARK3 | MAP/microtubule affinity-regulating kinase 3 | KP78; CTAK1; PAR1A | NM_002376 | | LVP196 | MAST2 | microtubule associated serine/threonine kinase 2 | FLJ39200, KIAA0807, MAST205, MTSSK, RP4-533D7.1 | NM_015112 | | LVP030 | MATK | megakaryocyte-associated tyrosine kinase | CHK; CTK; HYL; Lsk; HYLTK; HHYLTK; MGC1708; MGC2101; DKFZp434N1212 | NM_002378 | | LVP197 | MAX | MYC associated factor X | bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8 | NM_002382 | | LVP198 | MEF2B | myocyte enhancer factor 2B | hCG_38559, FLJ32648, RSRFR2 | NM_001145785.1 | | LVP199 | MEF2C | myocyte enhancer factor 2C | | NM_002397.3 | | LVP204 | MKNK1 | MAP kinase interacting serine/threonine kinase 1 | RP11-49P4.3, MNK1 | NM_003684 | | LVP229 | MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | ATLD, HNGS1, MRE11, MRE11B | NM_005590 | | LVP207 | MYD88 | myeloid differentiation primary response gene (88) | MYD88D | NM_002468 | | LVP111 | NBN | nibrin | AT-V1, AT-V2, ATV, FLJ10155, MGC87362, NBS, NBS1, P95 | NM_002485.4 | | LVP286 | NCOA4 | nuclear receptor coactivator 4 | ARA70; DKFZp762E1112; ELE1; PTC3; RFG | NM_001145263.1 | | LVP165 | NEK10 | NIMA (never in mitosis gene a)- related kinase 10 | FLJ32685 | NM_152534.3 | | LVP089 | NEK11 | NIMA (never in mitosis gene a)- related kinase 11 | FLJ23495 | NM_024800 | | LVP230 | NEK6 | NIMA (never in mitosis gene a)-related kinase 6 | RP11-101K10.6, SID6-1512 | NM_014397.4 | | LVP208 | NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | NFAT4, NFATX | NM_004555.2 | | LVP100 | NFIC | nuclear factor I/C (CCAAT-binding transcription factor) | CTF, CTF5, MGC20153, NF-I, NFI | NM_005597.2 | | LVP210 | NFkB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50 | NM_003998.3 | | LVP168 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | IKBA, MAD-3, NFKBI | NM_020529.2 | | LVP201 | NIM1 | serine/threonine-protein kinase | MGC42105 | NM_153361 | | LVP050 | NME1 | non-metastatic cells 1, protein | AWD, GAAD, NB, NBS, NDPK-A, NDPKA, NM23, NM23-H1 | NM_000269.2 | | LVP028 | NME5 | non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) | NM23H5; RSPH23; NM23-H5 | NM_003551 | | LVP110 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | B23, MGC104254, NPM | NM_002520.5 | | LVP108 | NR3C1 variant 1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | GCCR, GCR, GR, GRL | NM_001018077 | | LVP109 | NR3C1 variant 6 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | GCCR, GCR, GR, GRL | NM_001020825.1 | | LVP272 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | N-ras, RP5-1000E10.2, ALPS4, NRAS1, NS6 | NM_002524.3 | | LVP047 | NUAK2 | NUAK family, SNF1-like kinase, 2 | DKFZp434J037, DKFZp686F01113, FLJ90349, SNARK | NM_030952.1 | | LVP259 | OXSR1 | oxidative-stress responsive 1 | KIAA1101, OSR1 | NM_005109.2 | | LVP211 | PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | PAK65, PAKgamma | NM_002577.4 | | LVP231 | PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | | NM_001014831 | | LVP037 | PAK6 | p21 protein (Cdc42/Rac)-activated kinase 6 | PAK5 | NM_020168 | | LVP125 | PARS2 | prolyl-tRNA synthetase 2, mitochondrial (putative) | DKFZp727A071, MGC14416, MGC19467, MT-PRORS | NM_152268 | | LVP095 | PBK | PDZ binding kinase | CT84, FLJ14385, Nori-3, SPK, TOPK | NM_018492.2 | | LVP278 | PCBP2 | poly(rC) binding protein 2 | HNRPE2, hnRNP-E2 | NM_031989.4 | | LVP102 | PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | RP11-723P2.1, PDHA, PDHCE1A, PHE1A | NM_000284.2 | | LVP052 | PDIK1L | PDLIM1 interacting kinase 1 like | CLIK1L, RP11-96L14.4, STK35L2 | NM_152835.3 | | LVP060 | PDK3 | pyruvate dehydrogenase kinase, isozyme 3 | | NM_005391.4 | | LVP212 | PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | | NM_002612 | | LVP025 | PFKM | phosphofructokinase, muscle | GSD7; PFK1; PFKA; PFKX; PFK-1; MGC8699 | NM_000289 | | LVP213 | PHKG2 | phosphorylase kinase, gamma 2 (testis) | GSD9C | NM_000294 | | LVP214 | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1 | NM_006219 | | LVP215 | PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | DKFZp686P05226, FLJ41892, p55, p55-GAMMA | NM_003629 | | LVP062 | PIM1 | pim-1 oncogene | PIM | NM_002648.3 | | LVP034 | PIM2 | pim-2 oncogene | | NM_006875 |
|
|